| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| McBee Brannin | Chief Development Officer | C/O COREWEAVE, INC., 290 WEST MT. PLEASANT AVENUE, SUITE 4100, LIVINGSTON | /s/ Nisha Antony, as Attorney-in-Fact | 04 Dec 2025 | 0002058103 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRWV | Class A Common Stock | Sale | $31,865 | -418 | -14% | $76.23 | 2,582 | 02 Dec 2025 | Canis Major 2024 Irrevocable Trust LLC | F1, F2, F3 |
| transaction | CRWV | Class A Common Stock | Sale | $58,406 | -753 | -29% | $77.56 | 1,829 | 02 Dec 2025 | Canis Major 2024 Irrevocable Trust LLC | F1, F3, F4 |
| transaction | CRWV | Class A Common Stock | Sale | $69,070 | -881 | -48% | $78.40 | 948 | 02 Dec 2025 | Canis Major 2024 Irrevocable Trust LLC | F1, F3, F5 |
| transaction | CRWV | Class A Common Stock | Sale | $23,033 | -290 | -31% | $79.42 | 658 | 02 Dec 2025 | Canis Major 2024 Irrevocable Trust LLC | F1, F3, F6 |
| transaction | CRWV | Class A Common Stock | Sale | $20,446 | -254 | -39% | $80.50 | 404 | 02 Dec 2025 | Canis Major 2024 Irrevocable Trust LLC | F1, F3, F7 |
| transaction | CRWV | Class A Common Stock | Sale | $23,217 | -285 | -71% | $81.46 | 119 | 02 Dec 2025 | Canis Major 2024 Irrevocable Trust LLC | F1, F3, F8 |
| transaction | CRWV | Class A Common Stock | Sale | $9,787 | -119 | -100% | $82.24 | 0 | 02 Dec 2025 | Canis Major 2024 Irrevocable Trust LLC | F1, F3, F9 |
| transaction | CRWV | Class A Common Stock | Sale | $10,596 | -139 | -14% | $76.23 | 861 | 02 Dec 2025 | Canis Major 2025 Family Trust LLC | F1, F2, F10 |
| transaction | CRWV | Class A Common Stock | Sale | $19,469 | -251 | -29% | $77.56 | 610 | 02 Dec 2025 | Canis Major 2025 Family Trust LLC | F1, F4, F10 |
| transaction | CRWV | Class A Common Stock | Sale | $22,971 | -293 | -48% | $78.40 | 317 | 02 Dec 2025 | Canis Major 2025 Family Trust LLC | F1, F5, F10 |
| transaction | CRWV | Class A Common Stock | Sale | $7,704 | -97 | -31% | $79.42 | 220 | 02 Dec 2025 | Canis Major 2025 Family Trust LLC | F1, F6, F10 |
| transaction | CRWV | Class A Common Stock | Sale | $6,842 | -85 | -39% | $80.50 | 135 | 02 Dec 2025 | Canis Major 2025 Family Trust LLC | F1, F7, F10 |
| transaction | CRWV | Class A Common Stock | Sale | $7,739 | -95 | -70% | $81.46 | 40 | 02 Dec 2025 | Canis Major 2025 Family Trust LLC | F1, F8, F10 |
| transaction | CRWV | Class A Common Stock | Sale | $3,290 | -40 | -100% | $82.24 | 0 | 02 Dec 2025 | Canis Major 2025 Family Trust LLC | F1, F9, F10 |
| transaction | CRWV | Class A Common Stock | Sale | $265,139 | -3,478 | -14% | $76.23 | 21,522 | 02 Dec 2025 | Canis Major 2025 GRAT | F1, F2, F11 |
| transaction | CRWV | Class A Common Stock | Sale | $486,873 | -6,277 | -29% | $77.56 | 15,245 | 02 Dec 2025 | Canis Major 2025 GRAT | F1, F4, F11 |
| transaction | CRWV | Class A Common Stock | Sale | $575,060 | -7,335 | -48% | $78.40 | 7,910 | 02 Dec 2025 | Canis Major 2025 GRAT | F1, F5, F11 |
| transaction | CRWV | Class A Common Stock | Sale | $192,047 | -2,418 | -31% | $79.42 | 5,492 | 02 Dec 2025 | Canis Major 2025 GRAT | F1, F6, F11 |
| transaction | CRWV | Class A Common Stock | Sale | $170,654 | -2,120 | -39% | $80.50 | 3,372 | 02 Dec 2025 | Canis Major 2025 GRAT | F1, F7, F11 |
| transaction | CRWV | Class A Common Stock | Sale | $193,720 | -2,378 | -71% | $81.46 | 994 | 02 Dec 2025 | Canis Major 2025 GRAT | F1, F8, F11 |
| transaction | CRWV | Class A Common Stock | Sale | $81,748 | -994 | -100% | $82.24 | 0 | 02 Dec 2025 | Canis Major 2025 GRAT | F1, F9, F11 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.98 to $76.97, inclusive. |
| F3 | The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.98 to $77.97, inclusive. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.98 to $78.97, inclusive. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.98 to $79.96, inclusive. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $80.99, inclusive. |
| F8 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.00 to $81.99, inclusive. |
| F9 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.02 to $82.78, inclusive. |
| F10 | The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager. |
| F11 | The reported securities are directly held by the Canis Major 2025 GRAT, of which the reporting person is the sole trustee and beneficiary. |
This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person reported on Table I are continued on Part 3.